CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4

Biochemical and Biophysical Research Communications

Volumn 431, Issue 4, 2013, Pages 772-776

  Uto Konomi, Ayako ^a   McKibben, Bryan ^b   Wirtz, Julia ^a   Sato, Yayoi ^a   Takano, Ai ^a   Nanki, Toshihiro ^c   Suzuki, Shinobu ^a  

^a NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Arrestin; CXCL12; CXCR4; CXCR7

Indexed keywords

BETA ARRESTIN; CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7;

ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL;

CHEMOKINE CXCL12; DOWN-REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PYRIDINES; QUINOLONES; RECEPTORS, CXCR; RECEPTORS, CXCR4;

EID: 84875267735     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.032     Document Type: Article

References (21)

1. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
2. Kijima T., Maulik G., Ma P.C., Tibaldi E.V., Turner R.E., Rollins B., Sattler M., Johnson B.E., Salgia R. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res. 2002, 62:6304-6311.
3. Nanki T., Hayashida K., El-Gabalawy H.S., Suson S., Shi K., Girschick H.J., Yavuz S., Lipsky P.E. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 2000, 165:6590-6598.
4. Grassi F., Cristino S., Toneguzzi S., Piacentini A., Facchini A., Lisignoli G. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J. Cell. Physiol. 2004, 199:244-251.
5. Watanabe K., Penfold M.E., Matsuda A., Ohyanagi N., Kaneko K., Miyabe Y., Matsumoto K., Schall T.J., Miyasaka N., Nanki T. Pathogenic role of CXCR7 in rheumatoid arthritis. Arthritis Rheum. 2010, 62:3211-3220.
6. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., Arenzana-Seisdedos F., Thelen M., Bachelerie F. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 2005, 280:35760-35766.
7. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., Penfold M.E., Sunshine M.J., Littman D.R., Kuo C.J., Wei K., McMaster B.E., Wright K., Howard M.C., Schall T.J. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 2006, 203:2201-2213.
8. Kalatskaya I., Berchiche Y.A., Gravel S., Limberg B.J., Rosenbaum J.S., Heveker N. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol. Pharmacol. 2009, 75:1240-1247.
9. Rajagopal S., Kim J., Ahn S., Craig S., Lam C.M., Gerard N.P., Gerard C., Lefkowitz R.J. Beta-arrestin- but not G protein-mediated signaling by the " decoy" receptor CXCR7. Proc. Natl. Acad. Sci. USA 2010, 107:628-632.
10. Hartmann T.N., Grabovsky V., Pasvolsky R., Shulman Z., Buss E.C., Spiegel A., Nagler A., Lapidot T., Thelen M., Alon R. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J. Leukocyte Biol. 2008, 84:1130-1140.
11. Levoye A., Balabanian K., Baleux F., Bachelerie F., Lagane B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009, 113:6085-6093.
12. Naumann U., Cameroni E., Pruenster M., Mahabaleshwar H., Raz E., Zerwes H.G., Rot A., Thelen M. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 2010, 5:e9175.
13. Cruz-Orengo L., Holman D.W., Dorsey D., Zhou L., Zhang P., Wright M., McCandless E.E., Patel J.R., Luker G.D., Littman D.R., Russell J.H., Klein R.S. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 2011, 208:327-339.
14. Zabel B.A., Wang Y., Lewen S., Berahovich R.D., Penfold M.E., Zhang P., Powers J., Summers B.C., Miao Z., Zhao B., Jalili A., Janowska-Wieczorek A., Jaen J.C., Schall T.J. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J. Immunol. 2009, 183:3204-3211.
15. Hanson B.J., Wetter J., Bercher M.R., Kopp L., Fuerstenau-Sharp M., Vedvik K.L., Zielinski T., Doucette C., Whitney P.J., Revankar C. A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment. J. Biomol. Screen 2009, 14:798-810.
16. Doucette C., Vedvik K., Koepnick E., Bergsma A., Thomson B., Turek-Etienne T.C. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays. J. Biomol. Screen 2009, 14:381-394.
17. Kumar R., Tripathi V., Ahmad M., Nath N., Mir R.A., Chauhan S.S., Luthra K. CXCR7 mediated Gialpha independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells. Cell. Immunol. 2012, 272:230-241.
18. Kumar P., Lau C.S., Mathur M., Wang P., DeFea K.A. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2. Am. J. Physiol. Cell Physiol. 2007, 293:C346-C357.
19. Lymperopoulos A. Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors. Curr. Pharm. Des. 2012, 18:192-198.
20. Marchese A., Benovic J.L. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J. Biol. Chem. 2001, 276:45509-45512.
21. Canals M., Scholten D.J., de Munnik S., Han M.K., Smit M.J., Leurs R. Ubiquitination of CXCR7 controls receptor trafficking. PLoS One 2012, 7:e34192.